Pyrexia, commonly known as fever, is a symptom often encountered in clinical practice. It is a complex physiological response to disease, often indicating an underlying infection. Understanding its pathophysiology and appropriate management strategies is paramount to providing effective patient care.
Pyrexia is a rise in the body's core temperature, typically above 38°C, as a result of an increase in the hypothalamic set point. It is generally triggered by pyrogens, substances that can originate either externally (exogenous) from infectious agents, or internally (endogenous) from inflammatory cytokines.
Diagnosis of pyrexia involves a detailed history, thorough physical examination, and targeted investigations. It's crucial to identify the cause of the fever, which may range from common infections to malignancies or autoimmune diseases. Laboratory tests, imaging studies, and microbiological cultures are often required to identify the source.
Management of pyrexia involves treating the underlying cause and providing symptomatic relief. Antipyretics, such as paracetamol and non-steroidal anti-inflammatory drugs (NSAIDs), are commonly used to alleviate discomfort. However, their use should be judicious, considering their potential side effects. In cases of severe or persistent fever, hospitalization may be necessary for further evaluation and treatment.
Fever is not merely a symptom but also a defense mechanism of the body. It enhances immune response and inhibits the growth of certain pathogens. However, prolonged or excessively high fever can cause deleterious effects, such as seizures or organ damage, emphasizing the importance of timely intervention.
Pyrexia is a common clinical manifestation with a broad differential diagnosis. It requires a systematic approach for effective management. By understanding its pathophysiology, identifying the cause, and implementing appropriate treatment strategies, clinicians can significantly improve patient outcomes and comfort.
1.
Benefits of perioperative radiotherapy for liver cancer with a high risk of recurrence are investigated in research.
2.
Childhood cancer survivors face new health problems later in life, study shows
3.
Genomic Newborn Screening Could Identify Childhood Cancer Predisposition
4.
Coffee, Tea Tied to Lower Risk of Head and Neck Cancer
5.
Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer
1.
Obesity is a major risk factor for cancer
2.
Prevention of Thrombotic Complications in High-Risk Patients
3.
Tailoring the Immune Response: The Dawn of Personalized Vaccines in Cancer Immunotherapy
4.
Megakaryocyte Immune Cell Crosstalk: Mechanisms, Clinical Insights, and Therapeutic Implications
5.
The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part X
2.
Hands-on Workshop: Hematology
3.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
5.
Immunotherapy: A New Era in Cancer Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation